Gregory H. Jones, MD

  • 2Articles
  • 15.3KReads
  • 2022–2024Active
  • 13Collaborators
  • 12Citations

About

Gregory H. Jones, MD is affiliated with Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. Gregory H. Jones has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2022 and 2024. Their work focuses on Bipolar Disorder, Depression (MDD), Schizophrenia/Schizoaffective Disorders, and Veterans and Military Issues.

Publications

JCP
Antisuicidal Effects of Ketamine in Patients With Comorbid AUD
Original Research

Antisuicidal Effects of Ketamine in Patients With Comorbid AUD

April 24, 2024

Intranasal ketamine induced rapid antidepressant effects versus placebo but did not significantly change suicidal ideation scores in patients with alcohol use disorder and suicidal ideation with past attempt.
, , , et al
PCC
History of Suicide Attempt and Clozapine in Veterans With Schizophrenia
Original Research

History of Suicide Attempt and Clozapine in Veterans With Schizophrenia

November 1, 2022

This study evaluated whether a history of suicide attempt increases the odds of receiving clozapine treatment in veterans with schizophrenia or schizoaffective disorder.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe